Product Images Clopidogrel

This data shows the cumulative event rates (%) for cardiovascular death, myocardial infarction, and stroke over a period of 12 months of follow-up for patients who were given either placebo or clopidogrel in addition to aspirin. The numbers indicate a significant difference in event rates between the two groups, with clopidogrel showing a lower rate. Other standard therapies were also utilized in both groups.*

This document appears to be a medical chart or data table showing information related to the usage and effectiveness of various medications in a medical study or trial. It includes details regarding the history of heart-related incidents (MI, stroke), the administration of different medications (Heparin/LMWH, Aspirin, GPIIb/IIIa Antag, Beta-Blocker, Ace Inhibitor), and the outcomes in terms of the number and percentage of patients receiving Clopidogrel and Placebo. Additionally, there seems to be a comparison of outcomes favoring Clopidogrel versus Placebo and a hazard ratio analysis. *

This is a comparison of the cumulative event rate (%) of fatal or non-fatal vascular events between aspirin and clopidogrel over a period of 30 months of follow-up. The statistical significance of the results is indicated with p=0.045.*

This information compares the rate of death between patients who received a placebo and those who took Clopidogrel tablets. The data shows that there was a 7% proportional risk reduction in deaths in the group that took Clopidogrel tablets compared to the placebo group. The results are statistically significant with a p-value of 0.03. All treated patients in the study received aspirin.*

This text provides information on the comparison between Placebo and Clopidogrel Tablets in terms of the occurrence of events such as death, reinfarction, or stroke before discharge. It indicates a 9% proportional risk reduction with Clopidogrel Tablets compared to Placebo. The data represents patient outcomes over 28 days since randomization. All patients in the study received aspirin treatment.*

This data appears to be a table showing statistics related to a study or research on a particular treatment or intervention. It includes information on subgroups based on gender, age, time since onset, blood pressure, heart rate, and the administration of fibrinolytic agents. Additionally, there are results related to the administration of Clopidogrel tablets and placebo in different scenarios. Odds ratios and confidence intervals may also be mentioned for certain comparisons.*